Abstract:
A floor box for providing access to multiple utilities in a floor structure. The floor box includes a housing having a bottom wall and one or more side walls extending from the bottom wall and defining an interior space therebetween. A partition wall attached to the bottom wall and the side walls partially divides the interior space. A flange is attached at the upper edges of the side walls and includes a surface extending outwardly therefrom. A cover assembly includes a frame mounted to the flange. The frame has a cross member overlying the partition wall and cooperating therewith to divide the interior space into first and second compartments. The cover assembly further includes first and second access doors movable relative to the frame between open and closed positions for providing access to the first and second compartments respectively. A gasket seals the first and second compartments.
Abstract:
A method and device for controlling delivery of therapy in an implantable device that includes sensing a plurality of events, detecting whether there is an increase in the frequency of first events of the plurality of events corresponding to onset of a second event of the plurality of sensed events, adjusting parameters associated with delivery of the therapy in response to the detected increased frequency of first sensed events, and delivering the therapy using the adjusted parameters.
Abstract:
The invention is directed to techniques for applying overdrive pacing to one or both atria following termination of an AF episode, to prevent a recurrent AF episode. An implantable medical device such as a pacemaker applies overdrive pacing according to overdrive pacing parameters, and sets the parameters as a function of the response of the patient to overdrive pacing. The parameters may be adjusted upward or downward, so that overdrive pacing may be applied effectively but not over-applied.
Abstract:
The efficacy of cardiac resynchronization therapy applied to a patient's heart by an implantable device are improved by obtaining acute hemodynamic feedback during implantation of a pacing device. A first and a second transducer are temporarily placed proximate to a portion of the patient's heart during device implant, and a distance between the transducers is monitored as the therapy is applied. A parameter (e.g. lead location, biventricular pacing, pacing rate, or the like) of the cardiac therapy is adjusted in response to the distance between the transducers until a desired result is obtained, after which the first and second transducers can be removed from the patient.
Abstract:
A method and device for determining an optimal lower rate and adjusting the programmed lower pacing rate to the optimal rate that includes monitoring a parameter in response to therapy delivered at a first rate during a first time period to generate first parameter data, and determining whether the therapy was delivered for a predetermined portion of the first time period. The parameter is monitored in response to the therapy delivered at a next rate during a next time period to generate next parameter data, and a determination is made as to whether the therapy was delivered for a predetermined portion of the next time period. A metric corresponding to the first parameter data is determined to generate a first parameter metric, and corresponding to the next parameter data to generate a next parameter metric used for determining an optimal therapy delivery rate.
Abstract:
A pacing control is used in a multiple-chamber cardiac pacing system, which, upon detecting an atrial arrhythmia, automatically switches to a special therapy mode and administers a selected anti-tachycardia pacing (ATP) therapy in the atrium, and which switches to a standard pacing mode following delivery of the ATP therapy. The pacing control adjusts the timing of pacing pulses to be delivered to the atrium and/or the ventricle to minimize any potential ventricular pauses that may result from the switch from the therapy mode to the standard pacing mode.
Abstract:
An implantable medical device (IMD) senses physiological episodes and stores data associated with the physiological episodes in the IMD. The data is then processed based on a pattern of recurrence of the physiological episodes.
Abstract:
A laminate is disclosed that comprises at least two layers of fibrous nonwoven mats in which the majority of the fibers in at least one of the mats are glass fibers, the layers being bonded together with an adhesive, needling, stitch bonding or a mixture of two or more of these bonding techniques, one of the mats having a basis weight of at least 3 lbs. per 100 sq. ft and at least 1.5 times the basis wt. of the other mat. The laminates are especially useful in making acoustical panels for office partitions.
Abstract:
Control of defibrillation therapy delivered by implantable medical devices (IMDS) using hemodynamic sensor feedback is disclosed. The hemodynamic sensor feedback allows for increased control over application of atrial defibrillation therapy. Specifically, the therapy is delivered when a fibrillation episode results in a discrete loss of hemodynamic function. Defibrillation therapy is thus withheld for hemodynamically benign arrhythmias.
Abstract:
The disclosure relates to a process for continuous wet treatment of textile material in a container holding treatment liquid through which the material is being transported and is being penetrated by treatment liquid in a manner which is essentially vertical to its surface, and to devices for carrying out the process.In a particularly appropriate device, textile material 16 is introduced from the top into treatment liquid 28, then is guided around a minimum of one part (52, 80, 81, 120) which is arranged in the lower region of inner container (30, 85, 87, 119) liquid permeable to a limited degree, along a wall, and is thereby deflected and transported in the direction of the upper edge of inner container (30, 85, 87, 119).